Sihuan Pharmaceutical Holdings Group Ltd. (00460) has released its monthly return covering the period ended 28 February 2026. According to the report, the authorized share capital remains at 1.00 billion Hong Kong dollars, comprising 100.00 billion ordinary shares with a par value of HKD0.01 each. The number of issued shares stands at 9.15 billion, with an additional 0.18 billion treasury shares, resulting in a total of 9.33 billion shares.

The filing shows no changes in the company’s share capital structure during the month. Existing share option schemes adopted in October 2017 remain at 68.09 million total outstanding options, with no new shares issued or treasury shares transferred. The report also confirms compliance with the minimum public float requirement at a threshold of 25.00%. No other share warrants, convertibles, or similarly related agreements were reported for the period under review.